Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical formulations containing relacorilant, a heteroaryl-ketone fused azadecalin compound

Pharmaceutical formulations containing relacorilant, a heteroaryl-ketone fused azadecalin compound

US Patent 11464764 · Granted Oct 11, 2022

Estimated economic value: $34,860,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of preparing heteroaryl-ketone fused azadecalin glucocorticoid receptor 2024
Formulations of pyrimidine cyclohexyl glucocorticoid receptor modulators2024
Alkoxy compounds for disease treatment2024
Pharmaceutical formulations containing relacorilant, a heteroaryl-ketone fused a2024
Pharmaceutical formulations containing relacorilant, a heteroaryl-ketone fused a2024
Pharmaceutical formulations containing relacorilant, a heteroaryl-ketone fused a2024
Alkoxy compounds for disease treatment2022
Alkoxy compounds for disease treatment2020
Pharmacology of visual cycle modulators2019
Process for preparing an A2A-adenosine receptor agonist and its polymorphs2019
Styrenyl derivative compounds for treating ophthalmic diseases and disorders2019
Alkoxy compounds for disease treatment2019